1[1]Bortoloso E, Del Prete D, Gambaro G et al. Vascular endothelial growth factor(VEGF) and VEGF receptor in diabetic nephropathy: expression studies in biopsies of type 2 diabetic patients. Ren Fail, 2001, 23(3-4):483
2[2]Cooper ME, Vranes D, Youssel S et al. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes,1999, 48(11) :2229
3[3]Hoshi S, Shu Y, Yoshida F et al. Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats. Lab Invest, 2002, 82(1):25
4[4]D.R. Cha, S. Y. Han, S. Y. Lee et al. Vascular endothelial growth factor(VEGF) is increased in early stage of diabetic nephropathy. J Am Soc Nephrol, 2001, 12:832A
5[5]Couffinhal T, Kearney M, Witzenbichler B et al. Vascular endothelial growth factor/Vascular permeability factor(VEGF/VPF) in normal and atherosclerotic human arteries. AmJ Pathol, 1997, 150:1673
6[6]Li-Meng Chen, Xue-Wang Li. The relationship between ECM degradation and the expression of VEGF in the kidney of obese KKAy mice with type 2 diabetes. J Am Soc Nephrol, 2001, 12:144
7[7]Kim NH, Jung HH, Cha DR et al. Expression of vascular endothelial growth factor in response to high glucose in rat mesangial cells. J Endocrinol, 2000, 165(3) :617
8[8]Pupilli C, Lasagni L, Romagnani P et al. Angiotensin Ⅱ stimulates the synthesis and secretion of Vascular permeability factor/Vascular endothelial growth factor in human mesangial cells. J Am Soc Nephrol, 1999, 10(2) :245
9[9]Yuan HT, Yang SP, Woolf AS. Hypoxia up-regulates angiopoietin-2, a Tie-2 ligand, in mouse mesangial cells. Kidney Int, 2000, 58(5) :1912
10[10]Gruden G, Thomas S, Burt D et al. Interaction of angiotensin Ⅱ and mechanical stretch on vascular endothelial growth factor production by human mesangial cells. J Am Soc Nephrol, 1999, 10(4):730
4Helin I,Axenram M,Grubb A.Serum cystain C as a determinant of glomerular filtration rate in children[J].Clin Nephrol,1998,49(4);221-225.
5Renders E,Erlandsen E J,Pedersen O L,et al.Serum cystatin Cas a endogenous parameter of the renal function in patients with normal to moderately impaired kidney function[J].Clin Nephrol,2000,54(3):203-209.
6Cooper ME, Vranes D, Youssel S,et al. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes, 1999,48(11):2229
7Hoshi S, Shu Y, Yoshida F,et al. Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats. Lab Invest, 2002, 82(1):25
8Vlassara H,Bucala R,Striker L.Pathogenic effects of advanced glycosylation:biochemical,biologic and clinical implications for diabetes and aging[J].Lab Invest,1994,70(2):138-141.
9Ziyadeh FN.Significance of tubulointerstitial changes in diabetic renel disease[J].Kidney Int,1995,54(Supp 1):S10-S13.
